Tracer Biotechnologies

Business news, market intelligence, and global industry analysis.

The Latest

Could subcutaneous PD-1 therapy reshape oncology treatment logistics in China?

Cargo theft is rising across North America. Can Eagle Vision Security’s iFM platform stop it before it starts?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Representative image: A digital PCR setup with blood sample and amplification curves highlights the core technology behind Tracer Biotechnologies and Qiagen’s new MRD testing partnership for solid tumors.

Tracer Biotechnologies and Qiagen (NYSE: QGEN) forge oncology alliance to expand MRD testing

Qiagen partners with Tracer Biotechnologies to advance solid tumor MRD testing via QIAcuity. See how this impacts QGEN stock and oncology diagnostics.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

June 6, 2025